1513.HK · LIVZON PHARMA
Hong Kong · RS rating 41 · As of 2026-10-14
| Price | 21.04 HKD |
|---|---|
| 1-day change | -5.8% |
| RS rating (overall / 1M / 3M / 12M) | 41 / 80 / 24 / 38 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 18 / 18 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -25.9% |
| Distance from 52-week high | +40.4% |
| Market cap (USD) | $2.5B |